C.M.R. 10, 144, ch. 101, ch. I, § 144-101-I-5, subsec. 144-101-I-5.04

Current through 2024-51, December 18, 2024
Subsection 144-101-I-5.04 - PHARMACY SERVICES

The Department alters certain provisions of the MBM, Section 80, Pharmacy Services, as follows:

A.Initial Prior Authorization requirements for asthma and immune-related prescriptions: Restrictions on asthma related medications like Albuterol are removed to allow all forms of Albuterol without Prior Authorization. Restrictions on Immune-related medications, like Neupogen, are removed for approval with completion of Prior Authorization form, if necessary, for the treatment of COVID-19.
B.COVID-19 Treatments or Vaccines: Should COVID-19 specific treatments or vaccines become available during the duration of this emergency rule, Prior Authorization will be waived.
C.Prescription Refills: Early refills of prescription medications are allowed in the same days' supply and quantity as the original prescription; the requirements set forth in Ch. II, Sec. 80.07-7 are waived.
D.Buprenorphine and Buprenorphine Combination Products for Substance Use Disorder (SUD): The physical assessment requirements for Buprenorphine and Buprenorphine Combination Products for SUD set forth in Ch. II, Sec. 80.07-13 are waived.

C.M.R. 10, 144, ch. 101, ch. I, § 144-101-I-5, subsec. 144-101-I-5.04